FDMT · Forms 3, 4, 5
Insider trades at 4D Molecular Therapeutics, Inc.
1 insider sold $754K of 4D Molecular Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for 4D Molecular Therapeutics, Inc. (FDMT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| David Kirn | Director | Sell (10b5-1 plan) | 58,061 | $12.92 | $750K | Form 4 | |
| David Kirn | Director | Sell (10b5-1 plan) | 272 | $13.61 | $4K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Option exercise | 1,635 | $4.14 | $7K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Sell (10b5-1 plan) | 1,635 | $13.65 | $22K | Form 4 | |
| David Kirn | Director | Sell (10b5-1 plan) | 58,333 | $13.90 | $811K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Option exercise | 584 | $6.49 | $4K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Sell (10b5-1 plan) | 584 | $14.00 | $8K | Form 4 | |
| David Kirn | Director | Option exercise | 50,000 | $4.14 | $207K | Form 4 | |
| David Kirn | Director | Sell (10b5-1 plan) | 43,149 | $15.36 | $663K | Form 4 | |
| David Kirn | Director | Sell (10b5-1 plan) | 25,927 | $16.42 | $426K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Option exercise | 1,635 | $4.14 | $7K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Sell (10b5-1 plan) | 1,635 | $12.20 | $20K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Option exercise | 1,635 | $4.14 | $7K | Form 4 | |
| Scott Bizily | Chief Legal Officer | Sell (10b5-1 plan) | 1,635 | $12.00 | $20K | Form 4 | |
| David Kirn | Director | Sell (10b5-1 plan) | 26,842 | $10.23 | $275K | Form 4 | |
| David Kirn | Director | Sell (10b5-1 plan) | 12,415 | $10.05 | $125K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.